Clinical trials sponsored by British Columbia Cancer Agency

Phase breakdown

Conditions studied

Recruiting trials led by British Columbia Cancer Agency

• 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
  NCT04610372 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 4 locations
• CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease
  NCT05257967 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer
  NCT06665178 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
  NCT06628102 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Monitoring and Managing Glucose Levels in People With Pancreatic Cancer
  NCT05132244 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
  NCT06200974 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease
  NCT03836196 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer
  NCT06835725 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
  NCT02869802 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy
  NCT06885671 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Female · 1 location
• Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
  NCT06574620 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is British Columbia Cancer Agency recruiting for?

British Columbia Cancer Agency is the lead sponsor of 11 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.